Zdrowie i gospodarka · 21/08/2007

FDA Seeks Public Comment on Pharmacogenomic Data Submissions

The Food and Drug Administration (FDA) is requesting public input on the collection of pharmacogenomic data from drug sponsors, as part of the agency's efforts to streamline the drug development process.